Understanding heart, lung, and blood health over time
Official title: FRAMINGHAM HEART STUDY (FHS), TASK AREA A - CORE STUDY OPERATIONS
Funded at Boston University (Charles River Campus) · NIH-11305563 · Data updated 2026-11-12
This study is looking for people to help us learn more about what affects heart, lung, blood, and sleep health as we age, so we can find better ways to keep everyone healthy and understand how these conditions develop over time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | February 14, 2025 |
| Project end | February 13, 2026 |
| Funding year | 2025 |
| Award (this year) | $6,618,783 |
| NIH project number | 75N92025D00012-0-759202500001-1 |
| Project ID | NIH-11305563 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with a history of heart, lung, or blood disorders, as well as those interested in contributing to long-term health studies.
✕Less likely to help
Patients with no interest in participating in long-term studies or those with unrelated health conditions may not benefit from this research.
What this research studies
This research focuses on the Framingham Heart Study, which aims to gather and analyze data to better understand the factors that influence heart, lung, blood, and sleep disorders. By following participants over time, the study seeks to identify how risk factors change with aging and uncover new predictors of clinical events. Patients may be involved in providing biological samples and participating in clinical exams to help researchers gain insights into disease progression and health determinants.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for heart, lung, and blood disorders.
How similar studies have gone: Previous iterations of the Framingham Heart Study have successfully identified key risk factors for cardiovascular disease, indicating a strong potential for continued success with this approach.
Where this research is happening
-
Boston University (Charles River Campus)
Boston, United States Active
Researchers
- Principal investigator: Lloyd-Jones, Donald — Boston University (Charles River Campus)
- Study coordinator: Lloyd-Jones, Donald
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.